Mark McLean
Overview
Explore the profile of Mark McLean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Seifu C, Immanuel J, Hague W, Teede H, Cheung N, Hibbert E, et al.
Diabetes Care
. 2024 Mar;
47(12):e99-e101.
PMID: 38441605
No abstract available.
12.
Simmons D, Immanuel J, Hague W, Teede H, Nolan C, Peek M, et al.
Diabetes Care
. 2024 Feb;
47(12):2093-2101.
PMID: 38421672
Objective: In most gestational diabetes mellitus (GDM) studies, cohorts have included women combined into study populations without regard to whether hyperglycemia was present earlier in pregnancy. In this study we...
13.
Reyes P, Immanuel J, Hague W, Teede H, Hibbert E, Nolan C, et al.
Obes Sci Pract
. 2023 Dec;
9(6):573-580.
PMID: 38090691
Background: Both obesity and sleep disorders are common among women during pregnancy. Although prior research has identified a relationship between obesity and sleep disorders, those findings are from women later...
14.
Klaire S, Fairbairn N, Ryan A, Nolan S, McLean M, Bach P
J Addict Med
. 2023 Nov;
17(6):711-713.
PMID: 37934541
Objectives: Inpatient guidelines for methadone titration do not exist, whereas outpatient guidelines lack flexibility and do not consider individual opioid tolerance. The evaluation of rapid, adaptable titration protocols may allow...
15.
Fookeerah P, Varikatt W, Shingde M, Dexter M, McLean M
Endocr Connect
. 2023 Oct;
12(11).
PMID: 37851558
The application of transcription factor immunohistochemistry to pituitary neuroendocrine tumour (PitNET) assessment has allowed identification of tumours that do not conform to a single lineage. Multilineage pituitary transcription factor 1...
16.
Bradbury R, McLean M, Smith H
J Obstet Gynaecol Res
. 2023 May;
49(8):2194-2198.
PMID: 37211975
A 32-year-old nulliparous woman with premature ovarian insufficiency POI and autoimmune polyglandular syndrome type 2 (APS-2), presented to our fertility center with a 2.5-year history of amenorrhoea. Controlled ovarian hyperstimulation...
17.
Simmons D, Immanuel J, Hague W, Teede H, Nolan C, Peek M, et al.
N Engl J Med
. 2023 May;
388(23):2132-2144.
PMID: 37144983
Background: Whether treatment of gestational diabetes before 20 weeks' gestation improves maternal and infant health is unclear. Methods: We randomly assigned, in a 1:1 ratio, women between 4 weeks' and...
18.
19.
Fookeerah P, McLean M
Endocrinol Diabetes Metab Case Rep
. 2023 Feb;
2023(1).
PMID: 36815701
Summary: The anatomy of the pituitary fossa is complex. The wall of the fossa can vary, resulting in inconsistencies in the nature and integrity of the sella barrier. Cerebrospinal fluid...
20.
Nolan S, Fairgrieve C, Dong H, Garrod E, van Heukelom H, Parappilly B, et al.
J Addict Med
. 2022 Sep;
17(2):190-196.
PMID: 36149000
Objectives: A managed alcohol program (MAP) is a harm reduction strategy that provides regularly, witnessed alcohol to individuals with a severe alcohol use disorder. Although community MAPs have positive outcomes,...